Medtronic plc (NYSE:MDT) closed its last session at $84.68 with the change of -0.19%. The market capitalization of the company is $117.02B with an average Volume of 4.46 million shares. The stock currently has its 52-Week High range of $89.27 and 52-week low range of $63.98. The Price to Book (P/B) ratio stands at 2.31. The stock traded total quantity of 4.11 million shares.
Currently Medtronic plc (MDT) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “20″ Analysts”. “0” rated “Sell” for the company. “7” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $94.09 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $104.00 however minimum price target advised by analysts is $83.00. The Median price target for the stock is measured at $94.00.
Presently, Analysts decided consensus EPS estimate of $1.12 for present quarter and one month ago projected EPS estimate was at $1.14. If we take a look at back 3 month ago, consensus EPS estimate was $1.14.
A current consensus EPS estimate for next quarter is at $1.15 and 3 month ago EPS forecast was $1.15. Have a look at back 1 month ago, consensus EPS forecast was seen at $1.15.
For current fiscal year, most recent EPS estimate is set at $4.65 based on Analyst consensus and three month ago consensus EPS opinions was at $4.67. During period one month ago, consensus EPS forecast was decided at $4.66.
A current consensus EPS projection for next fiscal year is observed at $5.18 and one month ago consensus EPS forecast was at $5.17. Take a look at back three month ago, consensus EPS estimate opinions was decided at $5.17 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 17 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 1. 7 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 19 said a “Buy Rating” and 1 announced “Overweight Rating”. 7 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.